Study of BGM0504 injection for weight loss
Part of Hormones & metabolism clinical trials.
This study tests a new weekly injection (BGM0504) to help people with obesity or overweight lose weight. It may be an option if you have not had success with diet and exercise alone and meet certain health criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 65 years old.
- You have a BMI of 28 or higher, or a BMI between 24 and 28 with a weight-related health issue (like prediabetes, high blood pressure, or joint pain).
- Your weight has been stable (within 5%) for the past 3 months with diet and exercise.
- You are not pregnant or breastfeeding, and you use effective birth control if needed.
- You do not have diabetes, a history of pancreatitis, or untreated thyroid problems.
- You have not taken weight-loss or GLP-1 medications (like Ozempic) in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental pill, BGM0504, to see if it helps overweight or obese adults lose weight safely. Participants will take the pill while continuing their usual diet and exercise routine.
This study tests an investigational injection called UBT251 to help people who are overweight or obese lose weight. It may also improve related health issues like high blood pressure or fatty liver. The trial lasts for a period and includes regular check-ins with the study team.
This study tests a new medication called IBI3046 for people who are overweight or have obesity. The purpose is to see if it helps with weight loss and works safely.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
This study tests a new injection (MWN117) in healthy people and in people with obesity. It aims to see if the drug is safe and how the body handles it, which may eventually help with weight management.
This trial tests an investigational drug, BGM0504, for people recently diagnosed with type 2 diabetes who also have obesity. It aims to see if the drug can help control blood sugar and support weight loss.
Hear when a new Overweight or Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.